I
T HAS BEEN almost a decade since the first attempt was made to treat a child with hepatic glycogen storage disease by portal diversion.~s On the basis of animal experiments,23.28 it was hoped to make dietary glucose more readily available to peripheral tissues, to cOincidentally deglycogenate the liver, and to palliate other complications such as acidosis. This patient, as well as a second one described by Riddell, Davies, and Clark 21 had the operation of po~tacaval transposition, a procedure developed in dogs by Child· and associates 5 whereby the diverted portal inflow is replaced with venous blood from the suprarenal inferior vena cava.
Although the transposition was used in order to avoid the potential hazards of Eck fistula, it was suggested in our original report and in subsequent ones by Hermann and Mercer ll and ourselves 25 that an end-to-side portacaval anastomosis probably would be just as effective and that certainly it would be technically safer by virtue of omission of the second venous anastomosis. The simpler procedure of portcaval shunt has been used in all subsequent cases that have appeared in the literature 2 ,6,9 as well as for the last five cases in our series herein reported. Folkman and associates have recently shown that a further reduction of opera-tive risks in patients with glycogen storage should be pOSSible by parenteral hyperalimentation and consequent preoperative amelioration of hepatomegaly, acidosis, and other metabolic abnormalities. 9 The present communication has two general purposes. The first is clinical. Our own as well as the collected world experience with portal diversion for hepatic glycogen storage disease will be recounted, adding now to a total of 13 cases and including follow-ups of 9~ and 8 years, respectively, for our oldest patient and for Riddell's patient 21 who immigrated from Bristol, England, to Canada in 1968 . This latter boy was recently seen and studied in Denver along with our own six surviving patients. Emphasis will be placed on the long-term relief of the metabolic disturbances and growth retardation in patients with deficiency of three different kinds of enzymes: glucose-6-phosphatase (Type I), amylo-1-6-glucosidase (Type III), and phosphorylase (Type VI).
The second objective will be to consider the reasons why portal diversion has been so valuable, Partly on the basis of experiments recently carried out in dogs,:!\; it will be suggested that the multiple and striking benefits of portal diversion in glycogen storage disease de-STARZL AND OTHERS Ann. Surg .• October 1973 rive more from the bypassing of pancreatic hormones (particularly insulin) around the liver than by the simple rerouting of alimentary glucose as was originally believed.
Methods
There were seven patients in the Colorado series with the ages and the enzyme defects shown in Table 1 "'. In addition, the patient reported from Bristol, England, by Riddell, Davies and Clark 21 was studied including biopsy 7% years postoperatively. Determination of the " Typcs I, III, ano VI arc the hepatic glycogenoses which might theoretically benefit from portal diversion. At our institution, a 23-month-olU chilo from Christchurch, J\'ew Zealand, with Type IV glycogen storage diseasc (a-l,4-glucan: a-l,4-glucan 6 glycosyl transferase deficiency) received a side-to-sioe portacaval anastomosis but not with the metabolic objectives of the present report. With Type IV disease, an abnormal glycogen resemhling amylopectin which apparently causes a foreign body tissue reaction is deposited in the liver and causes progressive cirrhosis that leads to death at the age of 2 years or younger. The portacaval shunt was performed in -an attempt to control massive ascites but death followed 1 month later from hepatic insufficiency and a hemo)vtic crisis.
enzyme defects in the Colorado cases was by biochemical analysis in the St. Louis Laboratories of liver wedge biopsies which were obtained hefore or at the time of portacaval diversion and frozen on dry ice. The methods of analysis as well as the disease classification according to numerical types have been well accepted in standard endocrinology and metabolism texts. 3.13.22 The major complaints of the children or their parents were varia hIe ( Table 1) . All of the patients were stunted in growth and in Case 5 this was the most important complaint. Episodic hypoglycemia was documented in all but Case 5. Patients 2, 3 , and 4 (all Type I disease) had recurrent metabolic acidosis with lactic acidemia which had required numerous hospitalizations for therapy. The same three patients had repeated seizures. Other miscellaneous prohlems arc mentioned in Table 1 . Patients 6 and 7 were brother and sister; a sibling died at age 5, apparently of metabolic complicatiOns of glycogen storage disease. Two siblings of patient 2 died of hypoglycemia and acidosis.
The kind of portal diversion is indicated in Table 1 . Our first two patients had portacaval transposition; cnd-to-side portacaval shunt was used for the last 5. In Cases 3, 4, 6 , and 7 parenteral hyperalimentation as described by Folkman et al, 9 was used for 29, 13, 6, and 7 days. When performing the end-to-side portacaval shunts, all tributaries of the portal vein were ligated and divided from just above the pancreas to the division into the right and left portal branches. An elipse was removed from the vena cava. The back wall of the portacaval anastomosis was sutured from the inside and the anterior wall was completed externally.27 Postoperatively, hyperalimentation was continued until the patient resumed an oral diet and then tapered and discontinued from 6 to 8 days postoperatively. Growth was assessed by measurements of height and weight and by serial radiographic studies. The latter usually included wrist and hand X-rays, which were graded for bone age by the standards of Greulich and Pyle 10 and for osteoporosis. Because of the variahility of height measurements, lower extremity scanograms employing a calibrated steel rule were obtained. In Cases 3-7, serum alkaline phosphatase, calcium, phosphorus, and magnesium concentrations were obtained before and serially after operation and 24-hour urine calcium and phosphorus excretion was measured. These remained normal throughout except for a transient and minor hypocalcemia immediately postoperatively in four of the five patients in whom full data were obtained.
The effect of hyperalimentation and/or portal diversion upon liver size was determined quantitatively with colloidal gold (Case 1) or 99M technetium (Cases 3-7) sequential scans, using planimetry in some instances. Kidney size was followed by similar measurements of anteroposterior renal scans or by determining the supero-inferior length of the right or left kidney on intravenous urograms.
Standard liver function examinations were routinely ohtained before and after operation, including serum bilirubin, alkaline phosphatase, SGOT, SGPT, lactic dehydrogenase (LDH), prothrombin time, total protein and electrophoresiS, and plasma ammonia. Fasting venous plasma sugars, lactates, pyruvates, and pH's were measured. Five-hour glucose tolerance tests were performed with glucose sampling at 0, 30, 60, 90, 120, 180, 240 , and 300 minutes. In many of these tests insulin concentration 18 and pH of the venous blood samples were also analyzed.
The serum lipid components, cholesterol, triglycerides phospholipids (expressed as lecithin), and unesterified fatty acids were repeatedly examined hefore and after operation Lipoproteins were analyzed by cellulose acetate electrophoreSis in Cases 3-7 at frequent intervals, particularly in the patients with Type I disease.
Renal function was followed with blood urea nitrogen (BUN), creatinine and creatinine clearance determinations and with examination of urine electrolytes, urea, proteins and sediment; deterioration of function never occurred. Plasma uric acid concentration and urine uric acid secretion were measured.
Complete blood counts including white cell differential and quantitative platelet counts were followed. Minor abnormalities of several clotting factors have previously been reported for Case 1. 28 Patients 3-7 were screened for platelet defects prior to hyperalimentation or operation. The tests performed included a platelet count, Ivy bleeding time, prothrombin consumption,29 platelet aggregation," and in vitro platelet adhesiveness.31 Major abnormalities of platelet function were discovered only in Cases 3 and 4. These patients had Type I disease, and both had follow-up platelet studies.
Needle or open hiopsies were performcd from 4 to 113 months after portal diversion in all six of the surviving Colorado patients as well as in Riddell's patient. The tissues were examined by light microscopy for evidence of fibrosis, cirrhosis and hepatitis. The amount of fat in the cells was determined in frozen sections. 'Vhen pre-and postoperative biopsies were available the size of the hepatocytes before and after portal diversion were determined hy a method previously descrihcd. 2G Electron microscopy was also used on the biopsies from six of the eight patients. In addition to the histopathologic examinations, the postoperative tissues were measured for glycogen concentration and if there was sufficient tissue, analysis was carried out of the enzymes studied preoperatively.
In addition to studying the Colorado cases and Riddell's English patient, personal inquiries were· made about the fate of the other five patients reported in the literature to have had portal diversion procedures. Since this information was obtained in April, 1973 , follow-up data may be considered relatively complete for every patient known to have been submitted to this kind of surgical therapy.
Results

Mortality and Morbidity
Portacaval Transposition. Our first patient had a remarkably untroubled convalescence and was discharged from the hospital nine clays postoperatively. Before and after operation, there were elevations in the trans aminases (Table 2) , which even 9~ years later are still slightly increased. She had a splenectomy 43 months after transposition for thrombocytopenia at which timc the portacaval anastomosis draining the splanchnic bed was proved to be open. When this patient was seen 9~ years postoperatively in March, 1973, there was no .. Ghronolog plateJet aggrcgometer. eviden ce of portal hypertens ion indicating that the portacav al anastomosis draining th e splanchnic bed was still open. An inferior vena cavagram revealed flow of systemic venOllS blood from the distal vena cava to the liver but with a major bypass around the liver from azygous and hemiazygous collaterals (Fig. 1) . The degree of natural shunting was similar to that observed with a comparable angiographie study more than 9 years earli er wh en the patient was 3 months postopera-
tive.~~
The anastomosis through which the vena cava drains has failed in two other cases. The att empt at transposition cost the life of our second patient, when th e liver was unable to tran smit the rerouted vena caval flow , causi ng hepatic svvelling and uncontrollable aci- (Fig. 2, left) , a complication which probably occurred a long time previously since collateral venous channels were highly developed and lower limb edema was minimal. The anastomosis draining the splanchnic venous bed was shown to be open (Fig. 2,   right) .
End-to-Side Portacaval Shunt. Patients 3-7 all had rapid recovery without any clinically eviden t morbidity ascriba ble to the procedure. Significant increases in SCOT and SCPT were usually present at some time preoperatively both before and at the time of paren- teral hyperalimentation. After operation the trans aminasemia continued and the transaminase rises have been persistent in three of the five cases (Table 2) . Minor and transient elevations of lactic dehydrogenase and alkaline phosphatase were also noted.
None of the five patients was jaundiced immediately prior to operation, although patient 3 had had mild hyperbilirubinemia just before beginning hyper-alimentation. The bilirubin returned to and remained normal after operation. The other liver function tests, including serum protein electrophoresis, were always normal postoperatively.
The patients were placed on a normal diet after operation with no restrictions in protein intake. No clinical evidence of hepatic encephalopathy was observed and, in fact, the patients' parents without exception noted increased animation and mental acuity. Blood ammonia levels were always normal.
Effects on Growth
Thc remarkable increase in height in Case. 1 was reported previously.~R This child weighed 29 Kg. prior to operation and ,vas 124.5 cm. tall. Eleven months later she had gained 4)fKg. weight and 11Jf cm. in height. On the Harvard growth chart this jump in height represented a change from less than the 10th to the 50th percentile. By June, 1967, 44 months post-transplantation, her height had increased to 155 cm. At present, she is 172 cm. tall and weighs 82.7 Kg. Her weight and height positions on the growth chart are now over the 97th percentile levels.
Accelerated growth has now become evident in the three children with the longest follow-ups after endto-side portacaval anastomosis (Cases 3-5), averaging 0.5 to 1.0 cm. per month of height increase, as well as commensurate increases in the more accurately quantifiable long bone length in the 8Jf to 11Jf months of follow-up (Table 3 ). The phenomenal effects of doubling the bone age in Case 3 (Table 3 ) can be visually appreciated by comparison of the wrist and hands with X-ray examination (Fig. 3) . Patients 3, 4 and 5 also had calcification of previously osteoporotic bones. This was particularly striking in Case 5 (Fig. 4) . The last two patients have not yet begun accelerated growth.
Effect on Organ Size
Liver. As described by Folkman,9 both the patients with Type I disease (Cases 3 and 4) had declines in liver size following hyperalimentation and these decreases were maintained after end-to-side portacaval shunt. The child with Type VI disease (Case 5) was not prepared with hyperalimentation but he also had a postoperative decrease in hepatomegaly (Fig. 5 ). This effect of operation was not a striking feature of the recovery in Cases 1, 6, and 7. These children had Type III disease. The minimal or absent liver shrinkage was previously noted in Case l. 25.28 In that patient, it was pOinted out that with the increased body growth and fixed liver size, the child grew up around the enlarged organ to the extent that its relative although not its absolute size decreased.
Kidney. Kidneys in patients 4-7 appeared to have slight decreases (4 to 12 mm) in size during the 5 to 11 months of follow-up (Fig. 6 ). Quantitative data on kidney size was not available in Cases 1 and 3.
Metabolic Effects
Carbohydrates. With the exception of the child with Type VI disease (Case 5), all patients before operation had documented fasting hypoglycemia which caused symptoms. This was prllticlllarly severe in Cases 3 and 7 in which th e fastin g glucoscs were frcrillen tly below 15 mg./100 m1. (to as low as 7 mg,/ 100 mI.) , After portal diversion, symptomatic hypoglycemia was no longer a significant problem in patients 1, 6, and 7 (all Type III disease), The two children with Type I disease ( Cases 3 and 4 ) were improved but th ey were still unable to go without food for morc than 4 hours and 8 hours, respectively.
Pre-and postoperative 5-hour glucose tolerance tests were obtained in five of our six survivors. In the sixth ( Case 4), preopera tive tes ts could not b e obtained because of the need for continuous parenteral hyperalimentation. In Cases 1 and 3 th e glucose tol erance tests after 9)~ postoperative years and 1 year, respectively, had a considerably increased hyperglycemic responsc to the ingested sugar (Fig. 7) . The glucose tolerance tests in Cases 5, 6, and 7 were not much changed from 5 to 8 months after end-to-side portacaval shunt.
Insulin. Systemic insulin was measured during 5-hour glucose tolerance tests in our six survivors and in the Bristol case. The exa minations were 5, 5, 8~, 11, 11J~, 92 an d 113 months after portal diversion, The results are summarized in Figure 8 . Super norm al insulin rcsponses were observed in three cases, a normal response in a fourth , and su bnormal respons es in th e other three. The two patients who exhibited the Rattest insulin curves were the ones \.vith Rat glucose tolerance tests.
Lipids. Portal diversion caused a dramatic improvement of the hypcrlipidemia of Type I disease (Cases Flc. 4. Changes in the hand iwel wrist bones of Case 5 during 812 postoperative months. There was a gain in hand size, but the main change was rapid mineralization of the previously osteoporotic bones. The bracke ts on th e left index finger art' 7 em. 3 and 4, Table 4 ). All of the lipid components were brought toward normal ranges by preoperative hyperalimentation and the improvement was sustained after portacaval shunt. The evolution of recovery of lipid COJlstitlwnts in Case 4 is shown in Figure 9 , and in Figure 10 the lipid clearing is documented in terms of lipoprotein analysis.
Th e portal diversion also had an acutcly ameliorating effect upon the much It'ss severe hyperlipidemia affecting the two most recently treated patients with Typ e III dis ease (Cases 6 and 7, Table 4 ). Howevcr, patient 4 had recurrence of elevated lipids in one sample at 5 months. At thc same time, the boy's sister did not have worsening of lipid values. The lipids were esse ntially normal before and after operation in the pati ent with phosphorylase deficiency (Case 5).
Uric Acid. Four of the last five patients in the Colorado series had elevated serum uric acid concentrations. Aftt'r portal diversion, thes e concentrations fell either slightly or significantly in all four pati ents (Fig.  11) . Howcver, in Case 7, the uric acid was normal preoperatively and rose afterward just beyond normal range. P 1(1 telets. Major functional a bnorma Ii tics of pI atelets were present in pati E'n ts 3 and 4. They had abnormall y prolonged bl eE'ding times, decrcased platelet adhesiveness, abnormal platelet aggregation reactions, and decreascd prothrombin consumption. The abnormal platclet functions wcre rapidly corrected during intra vcnOll S hyperali men tation and remained normal afte r portal diversi on, as reported in detail elsewhere'
GrOl cth Hormone. Patients 3, 4 , and 5 had plasma somatotropin determinations after portal diversion. The same investigations were performed for an unoperated Sibling of patient 4 for whom portacaval shunt is planned. In all four patients, the levels and circadian patterns of somatotropin were normal as were the responses to arginine stimulation.
Histopathologic Studies
Preoperative liver biopsies were available from six of the eight patients. In all the cases the livcr cells were large and pale-staining and had ccntrally placed nuclei (Fig. 12, top) . The clear cytoplasm contained fat globules and much glycogen. The amount of reticulin in the portal tracts was increased and slender septa linked portal tracts and extended from th e enlarged portal trinds into the surrounding parenchyma (Fig. 13) . In two of the patients (Colorado Cases 6 and 7) this fibrosis was more extensive and the reitculin bands extended deeply into the lobules distorting the architecture and leading to the formation of small regeneration nodules and micronodular cirrhosis (Fig. 14) . Proliferation of the bile ductules and cellular infiltration of the septa were not features of these cirrhotic livcrs.
After portal diversion the size of the hepatocytes di- In both patients, the serum glucose after portal diversion showed higher and more persistent peaks.
minished (Fig. 12 , bottom) and the amount of fat in the cytoplasm of the liver cells increased. Both conditions persisted and were present as long as 1 year after operation (patient 3).
In two of the patients (Colorado Case 1 and the Bristol patient), only postoperative biopsies were available for study. In the Colorado case, cirrhosis had been a very prominent feature of the preoperative biopsy 9)f years previously as was recorded in the original case report,28 but the tissue block could not be found for re-study. There was no description of the hepatic morphology in the Bristol case report. By 1973, both these livers showed a micronodular cirrhosis similar to that present in Cases 6 and 7 but with the additional feature of some bile ductule proliferation in the enlarged portal tracts and in the fibrous septa. The hepatoeytes in these two cases contained much fat and glycogen and appeared smaller than normal but the lack of a preoperative biopsy for comparative study prevented any statement about the occurrence of atrophy after portal diversion.
--------------------
Tissue Chemistries
Tissues were examined from biopsies before portal diversion in all Colorado cases. After portal diversion, wedge biopsies were obtained in Case 1. Cases 3-7 had needle biopsies. The glycogen concentration was not altered from 5 to 113 months after portal diversion (Table 5) . Enzyme concentrations in Case 1 were reported to be unaltered in Case 1 after 9 and 43 months. There was not enough tissue in the needle biopsies of Cases 3-7 to permit repeating the enzyme analyses.
Follow-urJs Of Other Reported Cases
The fate as of April, i973, of all previously reported patients known to have been submitted to portal diversion is summarized in Table 6 , including the Bristol patient who was actually brought to Denver and studied. The patient operated upon in Cleveland in 1967 died p~ y~ars post-diversion of causes apparently unrelated to either the portal diversion or the enzymqtic defect for which it was performed. The other four children in whom portacaval shunts were performed have all benefited, in one instance despite thrombosis of the anastomosis.
Discussion
Recent animal work has indicated that the metabolic consequences of portal diversion are more complex as well as more profound than has been realized. The most important observations were with the kind of canine experiment that has been summarized schematically in terms of human anatomy in Figure 15 . In these investigations, the splanchnic venous return was divided so that one portion of th e dog liver received the venous efHuent from the intestine and W,lS thus Ilutritionally enriched but hormonally deprived. This hepatic tissue under'vvcnt deglycogenation and gross shrinkage as well as atrophy of the individual herat. ocytes. The other liver fragment was nourished by pancreatieo-gastroduodeno-splenic venous blood and was shown by a series of biochemical examinations to bc hormone-directed, particularly by pancreatic insulin and glucagon. Despite being deprived of intcstinal nutrients, the latter hepatic tissue und erwent glycogen storage, hyper trophy, and hyperplasia .2G T hus, under the special conditions of this kinu of "double liver fragment" experiment, rerouting of pan· creatic hormones around the normal dog liver ha d a far greater effect upon hepatiC structure and function th an the bypassing of vcnous blood rich in nutrients coming from the intestine. In trying to explain the ben· efits of portal diversion for glycogen storage dise ase, it is important to appreciate that with the procedures used for all our patients, both nutritional and hormonal substances were diverted extrahepatically and may havc contributed to the postoperative benefits.
Of the metabolic corrections produced by portal di. vei'sion , the most dramatic were in the patients with Type I disease (Cases 3 and 4). These involved lipids to an even greater extent than carbohydrates. The profound changes in lipid metabolism after portal diversion in patients with Type I disease was first noted by H ermann and Mercer l l and confirmed by Folkman et alB and in our own patients. The virtual normalization of all lipid constituents required only a few weeks for completion. The effect upon lipids did not seem to be secondary to a more fundamental change in carbohydrate metabolism. Repeat li ver biopsies did not show a changed concentration of glycogen. Furthermore, episodiC hypoglycemia \Vas not completely relieved by the portal diversion, although the seriousness of the problem was considerably reduced, as was the degree of accompanying acidosis. Both of these children with Type I disease continued to require supplemental night or early morning feedings. It was interesting that this requirement had long since disapp ea red for the Bristol patient who also had the glucose-6-phosphatase deficiency.
Similarly, the portal diversion did not change the glycogen concentration in the livers of the three children with Type III disease or the boy with the Type VI defect. The episodic hypoglycemia in two of the three patients with Type III disease could still be documented biochemically after long fasting or several hours after the ingestion of a glucose load, although again with less severity than preoperatively. In these cases, as well as in those with the Type I defect, some of the expected glycemic effects of diverting glucose · around the liver were probabl y cancelled by increasing the amount of insulin in the periphery. It is known that the liver extracts up to 50% of the endogenous insulin presented to it by th e first p,lSS of portal blood.1.l 6 . 19 \Vith avoidance of this primary exposure to the liver, Waddell and Sussman: 1o demonstrated increased systemiC venous insulin in dogs with Eck fistula and others have shown the same thin g in humans after portacaval Sh ulltl~2() A further hyperin sulinemic effect could then be caused after eating by stimulation of the pancrease by the arrival of a glucose load in the arterial circulation. Thus, failure to completely relieve hypoglycemiC symptoms by diverting alimentary glucose to the peripheral tissues Illay have been clue to one or the other or both the foregoing mech,1nisms.
Because insulins were not measured preoperatively in any of our longest surviving patients, the extent is not known to which portal diversion actually changed the concentration of this hormone in their sys tem iC blood. However, Lockwood et af. 1' and Dr, 1sh and FieldS have shown that victims of glycogen storage disease have abnormally low peripheral insulin concentrations under conditions of fasting or glucose ingestion. After portal diversion, all six of our survivors as FIC. 13. Biopsy from liver of patie nt 5 immediately before porta I diversion. The amount of re ticulin in the portal trac ts is in creased and sep ta link portal tra cts and ex te nd into the surrou nding p arenchyma. Silver stain for reti culin (X 70).
well as th e Bristol patient llacl insulin con cen tration s meas ured after stimulation with a glucose m eal. Th e responses were supernormal in three of the seven cascs and normal in a f ourth. Consequently , a reasonabl e although circumstantial case can be mad e that th e insulin supply to th e peripheral tissu es had been increasc d by the portal di version.
In recent yea rs, insulin has becn recognized to be a maj or grolVth horTll o I1 c,~~ cC ll1parabl e in potency to so matot ropin. It may he that th e phenomenal grolVth sp urts of all of our lon g-survivin g patien ts could be at least partly attribu tabl e to an increased insulin d istribution to the p c. : riphe ry. T he acccl eratecl grow th could not be expLri li ed hy other factors su ch as relief of chronic acidosis or persistent hypoglycemi a sin ce these werc some tim es not present prr peratively or else they were not comple tely corrected after th performance of the portacaval shun t. An effect on somatotropin would see m eq ually unlikely. In glycogen storage pati en ts studied by Dras b and Field," pl as ma g rowth hormon e has Iw cll normal and in the people studi ed by us with or witho ut portal d iversion, th e sa me was trlle.
It is not presen tl y possi ble to precisely expl ain all the meta bolic benefits of portal diversion by a si ngle hormonal or nutritional mech anism. " 'hy th e platelet dy sf unction should have been correc ted or why th e manifestations or ahnormal calciulll or uric ,leid metabolism should have been ameliorated are exam pl c5. The exact reaso n for the li ver shrinkage obse rv ed in several pati cn ts by li ver scans also is not apparent. Th e glycogen con ce ntration s were not altered after portal divcrsion. Howeve r, the biopsies obtained seve ral months Or longer after portal di version revealed pronounced hepatocyte atrophy. With this finding which , in turn is mos t likely the consequences of horm one d epriva tion (p articul<1rly in sulin) as discussed earlier, li ver shr inka ge co uld reasonably occur without an accompanying chan ge in glycogen concentr,ltion. ';\,lith the new .:ases in·11 Id 'd in th e present report, the posi tion has been reinforced that simpl ' end-to-side pO'l aca val sh unt is an effcctive and rela tively safe lllethod of palliating well selected patients with seve re manifes tations of hepatic glycogenosis. 'Vhen po rta l di ve rsion was first co nsidered for th ese dis eases, anxiety abou t th e complications of simple Eck fi st ula prompted attempts at the metabolically less damaging but technically more complicated operation of portacaval transposition. The fear that Eck fistula would have devastating effects on humans was based, at least in part, upon observations on two patients each by McDermott, Adams and Riddell 17 and Hubbard.14 These four patients had carcinomas of the head of the pancreas which involved the portal vein. To permit partial pancreatectomy, the portal vein was resected and an end-to-side anastomosis was made between the superior mesenteric vein and the inferior vena cava. Three of the four patients died of inanition and at autopsy there was massive fatty infiltration of the liver. The syndrome was ascribed to the bypass of ammonia of intestinal origin around the liver and it was generally accepted that Eck fistula in humans with normal livers would be exceptionally dangerous. The fact that partial pancreatectomy was also performed was lost sight of. The recent research already alluded to about the hepatotrophic effects of pancreatic hormones has raised the qu estion of whether or not the calamities of McDermott and Hubbard were not due at least as much to the pancreatic resection as to the portal-systemic venous diversion .
Be that as it may, the observations by us and by others authors have now established that simple endto-side portacaval anastomosis is weI! tolerated in children with Types I, III or VI glycogen storage disease. .:!.
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• (Cia tworth y ) Boston 9 . 3 7/71 (Folkman) Boston 9 2 11/71 (Folkman) have always been normal and at no time has there been evidence of hepatic encephalopathy. Although enzyme increases were observed for several days after the performance of end-to-side portacaval shunt, these unquestionably reflected pre-existing liver disease in most if not all of the cases. After operation, deterioration of liver function did not occur. Biopsies of the livers after portal diversion generally showed an increase in the amount of fat in the cytoplasm of the hepatocytes but did not show any progression in the amount of fibrosis or in the severity of the micronodular cirrhosis when this was present before operation. The frequency of scarring ranging from mild fibrosis to frank microndular cirrhosis in our cases before any operative intervention was surprising when the literature leads one to believe that fibrosis and cirrhosis are not complications of these types of glycogen storage disease. It is probable that closer attention to the pathologic findings will demonstrate a much higher incidence of fibrosis and cirrhosis than has been appreciated.
Summary
Seven patients with Types I, III, or VI glycogen storage disease were treated with portal diversion from 5)~ months to 9J~ years ago. The first two patients had portacaval transposition with one early death. The last five patients had the technically safer procedure of endto-side portacaval shunt without any deaths and with no late findings of hepatic encephalopathy. The convalescence of the patients with either kind of portal diversion has been characterized by accelerated body growth and bone mineralization, incomplete relief of hypoglycemia and metabolic acidosis, striking amelioration of the hyperlipidemia of Type I disease, liver shrinkage in Types I and VI disease, and variable relief of such diverse other derangements as abnormal bleeding and elevated serum uric acid concentrations. The liver concentrations of glycogen were not affected by portal diversion. However, the hepatocytes were decreased in size in subsequent biopsies, thereby accounting for the reduction of liver size in most of the cases without a major alteration in glycogen. Contrary to the impression conveyed by the literature, there was a high incidence of pre-existing coincidental liver disease in our patients, including transaminase elevations and hepatiC fibrosis or even cirrhosis. These abnormalities were particularly striking in Type III patients but did not appear in any of the cases to be made worse by portal diversion. The observations in these seven patients and in six more reported from other centers and followed up with personal examination by us in Denver or by personal communication with the responsible physicians elsewhere indicate that portal diversion should (26) in which one portion of the liver received portal venous inflow from the pancreas and the other portion received inflow from the intestine. The "food dominated" hepatic fragment underwent atrophy and deglycogenation whereas the "hormone dominated" fragment had hypertrophy, hyperplasia, and glycogen storage. These experiments which permitted dissociation of nutritional and hormonal influences indicated that the latter were more influential than the former in affecting liver structure and function.
have an important role in carefully selectcd cases of glycogen storage disease. Recent work in our laboratories has been reviewed which suggests that the effects of pOliacaval shunt are due more to the rerouting of pancreatic hormones around the liver than to the bypassing of alimentary glucose.
Leukocyte enzyme studies were performed and no amylo-l, 6 glucosidase activity was found. Normal levels of phosphorylase and amylo- ( 1, 6 )-transglucosidase were found.
Ill' came to the Universitv of Missouri Medical Center in Jannary 1973 with a 3-day history of melana and noticeahle orthostatic changes. Ill' gave a past history of peptic ulcer disease. However, an upper gastrointestinal series performed 6 months earlier at our institution showed only spasm in the duodenum. Castroduodenoscopy on admission revealcd no ulcer, only esophageal varices. Castric analysis was normal. Liver function tests wert' essentially normal except for an elevated alkaline phosphatase and LDH.
( Slide) A splenoportogram was performed and the splenic pulp pressure was 340 millimeters of saline. The X-rays were interpreted as showing evidence of portal hypertension.
After conferring with our gastroenterologist and finding some support for portal diversion ill Dr. Starzl's, Dr. Herman and Dr. Mercer's work, we decided to perform a side-to-side portacaval shunt. Portal venous pressures prior to construction of the shunt \\l'H' 275 millimeters of saline and after shunting were 185 millimeters of saline. A Dopplt'f ultrasonic flowmeter was used intraoperatively to confirm the patency of our shunt. Liver biopsy again rcveals irregular fibrosis, (slide) as seen in this reticulum stain; frozen section stained (slide) with PAS; and after diatase digestion (slide) demonstrates increased glvcogcn.
Postoperatively, a splenoportogram shows a (slide) patent portacaval anastomosis. The patient is now 3 months postoperative and doing well although he now manifests some evidence of diabetes with persistent hyperglycemia. I would like to ask Dr. Starzl if this has been a problem with any of his paticnts and sllotdd he now b(' managed as a diabetic?
Secondly, since cirrhosis has not been commonly reported in Typc III glycogen storagr' disease, I would like to ask if cirrhosis has been a common finding in his patients with Type III glycogen storage disease. DB. JUDAH F()LK~IAN (Boston): Children with glycogen storage disease suffer primarily because caloric intake gets trappcd as glycogen in the liver and cannot escape as glucose.
Thes(' children have hypoglycemic seizures. Their parents are often up all Ilight feeding th('m. They have acidosis. They have muscl(' wasting ancl above all, they do not grow, as Dr. Starzl pointed out.
Dr. Starzl was the first to realize, actually in 1963, that diversion of portal blood around the liver might make more glucose available to the peripheral circulation aftt'r each mcal and he carried out the first portal diversion for this disease.
In the intervcning years, there were four reports by surgeons each citing Oll(' case that he had clone of portal diversion for this disease, hut there was high morbidity and significant mortalitv because these little children are very sick going into the op('ration. Thn arc acidotic. Their pH is about 7.1 or 7.2. Their abdoJl]cn is filled with a hnge liver and this makes the operation difficult.
vVe have found that the operative risk could be reduced by preparing these children with 3 weeks of hyperalimentation. This cOITeds the acidosis and shrinks the liver to actually 50% of its size, reducl's the lipids to normal levels and makes the operation much more easy.
Last year, we reported two sneh cases to the Society of Univcrsity Surgeons in which hvperalimentatioll preceded portal caval shunt :lnd, like Dr. Starzl's cases, there was phenomenal growth after the shunt.
For example, in one of these boys-here he is at 20 months of age and 19 davs after a portal l'aval shnnt, \OU can see xanthomas wbich are disappearing because he has l~ml hyperalimentation. This liver looks !Jig now, but this is half of its original size before hyperalimentation. This is a picture taken 2 weeks ago, 1 year and ,3 months after operation and he is becoming a very big boy! He is eating all the time and growing and beginning to move from the fifth percentile to the ninety-fifth percentile. He is beginning to develop like a normal boy.
What is the mechanism besides redirection of glucose into the bloodstream? Dr. Starzl's elegant studies indicate that redirection of insulin directly into the vena cava without passage through the liver, also plays a role; that insulin in this situation may itself he a growth stimulant. When I read his paper and saw the abstract, I wished that I had thought of that because we had always assumed that the phcnomenal growth was primarily the result of increased glucose availabilitv. But, in fact, the tissue culture literature of recent years is filled with papers showing that insulin or insulin-like proteins ha:ve specific growth stimulating properties.
Several post-doctoral fellows in our laboratory have studied this effect in cultured cells. I, thus, have had the opportunity to observe at once the growth spurt in the cells and also in our two patients ... hnt, the importance of insulin in the growth of our patients did not occur to me as it did to Dr. Starz!' I can only put this down to "snowblindness." On the wall of our laboratory, we have listed the various pitfalls in the art of making obscrvations. Snowhlindness is one of them. It is the pitfall of making the wrong interpretation in the presence of all the right facts. An example par excellence is recorded in Lister's Commonplace-Books (now in the library of the Royal College of Surgeons). Aftcr Lister had become famous for establishing antiseptic surgery, he made another observation, recorded under the date, November 25, 1871. He noticed that numerous hacteria in a tube of urine were "completely immobile and languid." He also noticed the presence of a soft mold on the surface of the urine, which he thought was a penicillium mold. He made some experiments to see if the growth of mold made the liquid an unfavorable medium for bacteria. But he came to the erroneous conclusion that what was happening was a competitive struggle for oxygen, the penicillium absorbing oxygen contained in the broth and hlocking the surface.
vVe are indehted to Dr. Starz!'s group for showing llS that insulin may be acting as a growth stimulant. This contributes much to our understanding of the several beneficial effects of portal caval shunt in glycogen storage disease. Last, but not least, we are happy to see that they used hyperalimentation to prepare these children for shunt surgery, since this tends to confirm our own thinking that hyperalimentation reduces the operative risk in these patients. DR. T. E. STARZL (Closing): Concerning the snow blindness, I am strongly tempted to reveal examples of this disease of my own making but I will refrain because the crowd is so small and the time is so late that there would be an inappropriately small number of witnesses! Dr. Nichols, the literature leaves the probably crroneous impreSSion that glycogen storage disease is rarely associated with fibrosis. However, in our case material pre-existing fibrotic or cirrhotic disease was universal. This was a particularly important finding in the patients with Type III disease.
Concerning the elevated blood sugar levels in your patient after portacaval shunt, I have found in dogs made diabetic with alloxan that portal diversion is a slightly diabetogenic procedure for reasons that I do not think we have time to go into today (Surgery, 45:531, 1959 ). Dr. William Waddell has observed the same finding under somewhat different conditions of portal diversion. Such findings would go along with the events you saw in your patient, bllt I wOllld not antiCipate management of the diabetes would be a serious problem.
As Dr. Folkman said, the role of insulin in accelerating the growth of these shlllted children is one of the key questions raised by my presentation today. Reflecting hack 40 or 50 years ago, it may be recalled that there were "diahetic dwarfs" in those davs before hormone therapy became available. This complication is not seen anymore for obvious reasons. But it is possible that the diabetic dwarfs of that era and the dwarfism that is seen in the glycogen storage disease patients of today have the common explanation of insulinopenia.
